Merck & Co Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Well, great. Good morning, everybody, and thanks for joining us for the next session. I'm Matthew Harrison, one of the biopharma analysts here at Morgan Stanley. Very pleased to have Merck with us for the next session.
Before we get started, I need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures.
So pleased to have Rob Davis, the CEO of Merck; and Dean Li, who runs R&D. Rob, I'm going to turn it over to you to make some opening comments, and then we can jump into Q&A.
Great. Well, thank you. Thanks, Matt, and thank you for having us. We can obviously get into this more in the question and answers, but I think it's important just for everyone to understand. It's an exciting time at Merck. We feel very good
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
